
In order to prevent and control major Non-Communicable Diseases, Government of India is implementing the NPCDCS in all States across the country with the focus on strengthening infrastructure, human resource development, health promotion, early diagnosis, management and referral. Progress so...
Read MoreAyushman Bharat-Health & Wellness Centres (AB-HWC) Delivery of comprehensive primary health care services through Health &Wellness Centres is a critical component of the newly announced Ayushman Bharat scheme. It places people and communities at the center of the health care...
Read MoreZydus Cadila has received the final approval from the USFDA to market Betamethasone Dipropionate Cream USP (US RLD – DIPROLENE® AF), 0.05%. It will be manufactured at the group’s Topical manufacturing facility at Ahmedabad. This medication is a strong corticosteroid...
Read MoreDrug maker Lupin is in the process of developing a pipeline of products under its new drug discovery programme to treat various diseases like cancer and metabolic disorders, a top company official said. The company, which last month inked a...
Read MoreEli Lilly and Company (NYSE: LLY) and Loxo Oncology, Inc. have announced a definitive agreement for Lilly to acquire Loxo Oncology for $235.00 per share in cash, or approximately $8.0 billion. Loxo Oncology is a biopharmaceutical company focused on the...
Read MoreThe Hon’ble Union HRD Minister, launched the IIC program under the Innovation Cell at AICTE, with a purpose to systematically foster a culture of innovation in all Higher Education Institutions across the nation. Talking about Inventive Step, Ms. Shwetasree Majumder,...
Read MorePrime Minister Narendra Modi unveiled today the state of art, super-speciality public hospital - Sardar Vallabhbhai Patel Institute of Medical Sciences and Research in Ahmedabad today. Built by Ahmedabad Municipal Corporation, the 78 meter high, 1500 bed hospital is equipped...
Read MoreAurobindo Pharma Limited, announces the signing of a definitive agreement to acquire a portfolio of seven branded oncology injectable products from Spectrum pharmaceuticals Inc. The acquisition also brings-in an experienced branded commercial infrastructure in the US. Acrotech Biopharma LLC (“Acrotech”),...
Read MoreZydus Cadila has received the final approval from the USFDA to market Acetazolamide ER Capsules (US RLD – Diamox). It will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad. Acetazolamide is a potent carbonic anhydrase inhibitor. Acetazolamide...
Read MoreStatement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research: The FDA is witnessing a surge of cell and gene therapy products entering early development, evidenced by a large...
Read MoreAccuprec Research Labs Pvt. Ltd. © 2025